Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

WECARE: A Personalized Intervention for High-Demand Dementia Caregivers (WECARE 3)

21 septembre 2026 mis à jour par: Y. Alicia Hong, George Mason University

The goal of the project is to evaluate Wellness Enhancement for Caregivers (WECARE), a digital behavioral intervention for high-demand dementia caregivers. The behavioral intervention is culturally tailored to the target users and will be delivered via the WECARE mobile app and accompanying website, accessible only to verified enrolled participants. Participants will engage with digital learning materials and supportive resources over the course of the program. The goal is to determine whether this approach improves caregiver well-being and reduces stress related to caregiving.

Aperçu de l'étude

Statut

Pas encore de recrutement

Les conditions

Type d'étude

Interventionnel

Inscription (Estimé)

200

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Kang Shen
  • Numéro de téléphone: 7039931929
  • E-mail: kshen2@gmu.edu

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

21 ans à 100 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  1. currently residing in the United States,

  2. are 21 years of age or older,

  3. own a smartphone or computer, AND

  4. currently care for a family member or loved one who lives of Alzheimer's disease or related dementia and meet one of hte following high-demand criteria:

    1. age 65 or older,
    2. provide 10 or more hours of direct care per week,
    3. work 20 or more hours per week in addition to caregiving,
    4. care for another family member (e.g., a child under 18, another parent, or a spouse); or
    5. experience difficulty covering basic living expenses.

Exclusion Criteria:

  1. evidence or signs of severe cognitive impairment or mental disorders,
  2. the care recipient was receiving hospice care or had a life expectancy of fewer than six months, OR
  3. Unable to provide informed consent

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Intervention group

Participants will first complete a baseline survey online, then access the WECARE program via a project-specific mobile app (WECARE) or its accompanying website and begin receiving the 7-week interactive and personalized program. The program content includes short video clips, pictorial messages, and audio recordings. Each week, the WECARE program is focused on a theme aimed to increase participants' caregiving mastery, enhance self-care, and improve psychosocial wellbeing. Four weeks after the intervention or 11 weeks after the baseline, participants will complete the follow-up survey online. Six months after the baseline, participants will complete the second follow-up survey online. Tweleve months after the baseline, participants will complete the third follow-up survey online.

The 7-week WECARE intervention was designed to improve caregiving skills, alleviate caregiver distress, and enhance the psychosocial well-being of dementia caregivers. The program content includes short video clips, pictorial messages, and audio recordings tailored participants characteristics (e.g., caregiver role, baseline caregiving burden) and personalized to their individual needs based on weekly feedback.

Comparateur actif: Control Group

Participants in this arm will receive equal attention intervention. They will also access the WECARE app and accomanying website to receive the 7-week program featured in general health education. Each week, participants receive health information with a focused theme at the same frequency as the intervention group. Four weeks after the intervention or 11 weeks after the baseline, participants will complete the first follow-up survey online. Six months after the baseline, participants will complete the second follow-up survey online. Tweleve months after the baseline, participants will complete the third follow-up survey online.

Participants will access the the same WECARE app and accomanying website to receive the 7-week program featured in general health education. Each week, participants receive health information with a focused theme at the same frequency as the intervention group.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Efficacy of Behavioral Intervention in Change From Baseline in Depressive Symptoms
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in depressive symptoms will be assessed using the Center for Epidemiologic Studies Depression Scale (CES-D). The CES-D is a 20-item survey instrument designed to measure the frequency and severity of depressive symptoms. The total score is calculated by summing the responses to all 20 items. The total scale ranges from 0 to 60, with higher scores indicating more severe depressive symptoms (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

adults and dementia caregivers.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Efficacy of Behavioral Intervention in Change From Baseline in Caregiving Burden
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in caregiving burden will be assessed using the 12-item Zarit Burden Interview (ZBI-12). The ZBI-12 is designed to measure the subjective physical, psychological, and social burden experienced by caregivers. Each item is rated on a 5-point scale from "never" (0) to "nearly always" (4), The total score is calculated by summing the responses to all 12 items. The total scale ranges from 0 to 48, with higher scores indicating greater caregiving burden (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

Autres mesures de résultats

Mesure des résultats
Description de la mesure
Délai
Efficacy of Behavioral Intervention in Change From Baseline in Life Satisfaction
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in life satisfaction will be assessed using the Satisfaction with Life Scale (SWLS). The SWLS is a 5-item survey instrument designed to measure a person's global cognitive judgments of satisfaction with their life. The total score is calculated by summing the responses to all 5 items. The total scale ranges from 0 to 30, with higher scores indicating greater life satisfaction (a better outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)
Efficacy of Behavioral Intervention in Change From Baseline in Caregiving Mastery
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in caregiving mastery will be assessed using the Caregiving Mastery Scale. This 7-item survey instrument is designed to measure a caregiver's self-perception of their ability to effectively manage caregiving tasks and challenges. The total score is calculated by summing the responses to all 7 items. The total scale ranges from 0 to 28, with higher scores indicating greater caregiving mastery (a better outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)
Efficacy of Behavioral Intervention in Change in Care-recipient's Problem Behaviors
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in care-recipient problem behaviors will be assessed using the Revised Memory and Problem Behavior Checklist (RMBPC). The RMBPC is a 24-item survey instrument designed to measure observable behavioral problems in care recipients across three subdomains: memory-related issues, depressive behaviors, and disruptive behaviors. The total score is calculated by summing the Yes (1) or No (0) responses to all 24 items. The total scale ranges from 0 to 24, with higher scores indicating a higher frequency of problem behaviors (a worse outcome). The primary analysis will calculate the difference in this total score between baseline and follow-up.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)
Efficacy of Behavioral Intervention in Change From Baseline in Positive Aspect of Caregiving
Délai: Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

The baseline and follow-up differences in caregivers' positive aspects of caregiving will be measured by Positive Aspects of Caregiving Scale, a 9-item scale 5-point Likert scale from 0 to 4, with total scores ranging from 0 to 36, with higher score indicating more positive perception of caregiving. The baseline and follow-up differences in the scores will be calculated.

Baseline, and Follow-Up at Weeks 11-12 (4 to 5 weeks after completion of the intervention)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

2 novembre 2026

Achèvement primaire (Estimé)

1 septembre 2030

Achèvement de l'étude (Estimé)

1 octobre 2030

Dates d'inscription aux études

Première soumission

13 avril 2026

Première soumission répondant aux critères de contrôle qualité

13 avril 2026

Première publication (Réel)

20 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

23 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

21 septembre 2026

Dernière vérification

1 septembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • MOD00001548
  • R01AG090610 (Subvention/contrat des NIH des États-Unis)

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner